Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.14 Billion CNY | 11.77% |
| 2022 | 2.76 Billion CNY | -10.57% |
| 2021 | 3.08 Billion CNY | -0.59% |
| 2020 | 3.1 Billion CNY | -22.33% |
| 2019 | 4 Billion CNY | -1.73% |
| 2018 | 4.07 Billion CNY | 44.85% |
| 2017 | 2.81 Billion CNY | 33.81% |
| 2016 | 2.1 Billion CNY | 9.51% |
| 2015 | 1.91 Billion CNY | 6.23% |
| 2014 | 1.8 Billion CNY | 17.14% |
| 2013 | 1.54 Billion CNY | 6.89% |
| 2012 | 1.44 Billion CNY | 29.39% |
| 2011 | 1.11 Billion CNY | 21.3% |
| 2010 | 918.72 Million CNY | 35.31% |
| 2009 | 678.96 Million CNY | 36.51% |
| 2008 | 497.38 Million CNY | -8.73% |
| 2007 | 544.96 Million CNY | 44.34% |
| 2006 | 377.56 Million CNY | 11.07% |
| 2005 | 339.92 Million CNY | 46.8% |
| 2004 | 231.55 Million CNY | 29.47% |
| 2003 | 178.84 Million CNY | -1.11% |
| 2002 | 180.85 Million CNY | 3.35% |
| 2001 | 174.99 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 667.04 Million CNY | -14.95% |
| 2024 Q1 | 784.31 Million CNY | 12.03% |
| 2024 Q3 | 625.79 Million CNY | -13.37% |
| 2023 Q3 | 658.07 Million CNY | -11.38% |
| 2023 Q4 | 700.12 Million CNY | 6.39% |
| 2023 Q1 | 987.27 Million CNY | 52.41% |
| 2023 FY | 3.08 Billion CNY | 11.77% |
| 2023 Q2 | 742.54 Million CNY | -24.79% |
| 2022 Q1 | 771.95 Million CNY | 1.26% |
| 2022 FY | 2.76 Billion CNY | -10.57% |
| 2022 Q2 | 629.07 Million CNY | -18.51% |
| 2022 Q3 | 714.07 Million CNY | 13.51% |
| 2022 Q4 | 647.79 Million CNY | -9.28% |
| 2021 Q1 | 823.68 Million CNY | 13.52% |
| 2021 Q3 | 761.69 Million CNY | 2.72% |
| 2021 Q4 | 762.36 Million CNY | 0.09% |
| 2021 FY | 3.08 Billion CNY | -0.59% |
| 2021 Q2 | 741.55 Million CNY | -9.97% |
| 2020 Q4 | 725.55 Million CNY | -2.26% |
| 2020 FY | 3.1 Billion CNY | -22.33% |
| 2020 Q3 | 742.34 Million CNY | 3.04% |
| 2020 Q2 | 720.47 Million CNY | -21.28% |
| 2020 Q1 | 915.27 Million CNY | 13.52% |
| 2019 Q2 | 1.18 Billion CNY | 18.9% |
| 2019 Q3 | 1.01 Billion CNY | -13.67% |
| 2019 Q1 | 992.67 Million CNY | 5.93% |
| 2019 FY | 4 Billion CNY | -1.73% |
| 2019 Q4 | 806.28 Million CNY | -20.87% |
| 2018 Q2 | 1.03 Billion CNY | -0.71% |
| 2018 FY | 4.07 Billion CNY | 44.85% |
| 2018 Q4 | 937.1 Million CNY | -10.45% |
| 2018 Q1 | 1.04 Billion CNY | 18.39% |
| 2018 Q3 | 1.04 Billion CNY | 0.88% |
| 2017 FY | 2.81 Billion CNY | 33.81% |
| 2017 Q4 | 882.46 Million CNY | 8.11% |
| 2017 Q3 | 816.29 Million CNY | 34.93% |
| 2017 Q2 | 604.96 Million CNY | 20.05% |
| 2017 Q1 | 503.92 Million CNY | -9.39% |
| 2016 Q3 | 530.46 Million CNY | 1.6% |
| 2016 FY | 2.1 Billion CNY | 9.51% |
| 2016 Q4 | 556.13 Million CNY | 4.84% |
| 2016 Q2 | 522.09 Million CNY | 7.37% |
| 2016 Q1 | 486.25 Million CNY | 0.44% |
| 2015 Q2 | 487.37 Million CNY | 9.67% |
| 2015 FY | 1.91 Billion CNY | 6.23% |
| 2015 Q1 | 444.38 Million CNY | -16.96% |
| 2015 Q4 | 484.11 Million CNY | -1.43% |
| 2015 Q3 | 491.13 Million CNY | 0.77% |
| 2014 Q2 | 432.04 Million CNY | 10.12% |
| 2014 Q3 | 441.95 Million CNY | 2.29% |
| 2014 Q4 | 535.18 Million CNY | 21.09% |
| 2014 FY | 1.8 Billion CNY | 17.14% |
| 2014 Q1 | 392.33 Million CNY | -5.06% |
| 2013 Q4 | 413.25 Million CNY | 3.35% |
| 2013 Q2 | 358.07 Million CNY | -1.33% |
| 2013 Q1 | 362.88 Million CNY | -9.94% |
| 2013 FY | 1.54 Billion CNY | 6.89% |
| 2013 Q3 | 399.87 Million CNY | 11.68% |
| 2012 FY | 1.44 Billion CNY | 29.39% |
| 2012 Q1 | 349.91 Million CNY | 12.16% |
| 2012 Q4 | 402.92 Million CNY | 10.67% |
| 2012 Q3 | 364.06 Million CNY | 13.77% |
| 2012 Q2 | 319.99 Million CNY | -8.55% |
| 2011 Q3 | 274.28 Million CNY | 16.52% |
| 2011 Q2 | 235.39 Million CNY | -5.29% |
| 2011 Q1 | 248.53 Million CNY | -0.02% |
| 2011 FY | 1.11 Billion CNY | 21.3% |
| 2011 Q4 | 311.98 Million CNY | 13.74% |
| 2010 Q2 | 227.11 Million CNY | 4.09% |
| 2010 Q1 | 218.19 Million CNY | 1.88% |
| 2010 FY | 918.72 Million CNY | 35.31% |
| 2010 Q4 | 248.59 Million CNY | 10.57% |
| 2010 Q3 | 224.81 Million CNY | -1.01% |
| 2009 Q3 | 201.23 Million CNY | 57.91% |
| 2009 Q2 | 127.44 Million CNY | -6.37% |
| 2009 Q1 | 136.1 Million CNY | 10.02% |
| 2009 FY | 678.96 Million CNY | 36.51% |
| 2009 Q4 | 214.17 Million CNY | 6.43% |
| 2008 Q3 | 122.25 Million CNY | -3.94% |
| 2008 Q4 | 123.7 Million CNY | 1.19% |
| 2008 FY | 497.38 Million CNY | -8.73% |
| 2008 Q1 | 124.15 Million CNY | -1.62% |
| 2008 Q2 | 127.26 Million CNY | 2.51% |
| 2007 Q2 | 102.37 Million CNY | 14.83% |
| 2007 Q1 | 89.15 Million CNY | -35.0% |
| 2007 FY | 544.96 Million CNY | 44.34% |
| 2007 Q3 | 134.21 Million CNY | 31.1% |
| 2007 Q4 | 126.2 Million CNY | -5.97% |
| 2006 Q1 | 81.48 Million CNY | -11.61% |
| 2006 Q2 | 60.43 Million CNY | -25.84% |
| 2006 Q3 | 98.47 Million CNY | 62.96% |
| 2006 Q4 | 137.16 Million CNY | 39.29% |
| 2006 FY | 377.56 Million CNY | 11.07% |
| 2005 Q1 | 64.39 Million CNY | 3.19% |
| 2005 Q4 | 92.18 Million CNY | -2.71% |
| 2005 Q3 | 94.76 Million CNY | 6.98% |
| 2005 FY | 339.92 Million CNY | 46.8% |
| 2005 Q2 | 88.58 Million CNY | 37.55% |
| 2004 FY | 231.55 Million CNY | 29.47% |
| 2004 Q1 | 48.53 Million CNY | 74.3% |
| 2004 Q2 | 54.42 Million CNY | 12.14% |
| 2004 Q3 | 66.19 Million CNY | 21.62% |
| 2004 Q4 | 62.4 Million CNY | -5.72% |
| 2003 Q4 | 27.84 Million CNY | -47.15% |
| 2003 Q3 | 52.68 Million CNY | 0.0% |
| 2003 FY | 178.84 Million CNY | -1.11% |
| 2002 FY | 180.85 Million CNY | 3.35% |
| 2001 FY | 174.99 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 14.38 Billion CNY | 78.109% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.3 Billion CNY | -140.458% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.08 Billion CNY | -189.945% |
| Aurora Optoelectronics Co.,Ltd. | 482.31 Million CNY | -552.873% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 64.1 Million CNY | -4812.41% |
| NanJing Pharmaceutical Company Limited | 2.3 Billion CNY | -36.562% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 818.48 Million CNY | -284.727% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.08 Billion CNY | -189.084% |